Literature DB >> 8751582

Coenzyme Q10 protects coronary endothelial function from ischemia reperfusion injury via an antioxidant effect.

H Yokoyama1, D M Lingle, J A Crestanello, J Kamelgard, B R Kott, R Momeni, J Millili, S A Mortensen, G J Whitman.   

Abstract

BACKGROUND: Cardiac ischemia reperfusion (I/R) injury causes coronary vascular dysfunction. Coenzyme Q10 (CoQ), which preserves cardiac mechanical function after I/R, recently has been recognized as a free radical scavenger. We hypothesized that CoQ protects coronary vascular reactivity after I/R via an antioxidant mechanism.
METHODS: Rats were pretreated with either CoQ (20 mg/kg intramuscular and 10 mg/kg intraperitoneal [CoQ group]) or a vehicle (Control) before the experiment. Isolated perfused rat hearts were subjected to 25 minutes of global normothermic ischemia and 40 minutes of reperfusion. The reperfusion-induced oxidative burst was directly assessed by lucigenin enhanced chemiluminescence. Coronary flow was measured at equilibration and after reperfusion with or without bradykinin, an endothelium-dependent vasodilator, and sodium nitroprusside (SNP), an endothelium-independent vasodilator. The effect of intracoronary infusion of hydrogen peroxide (H2O2 0.1 mumol/gm body weight given over 5 minutes), simulating the free radical burst after I/R, also was evaluated.
RESULTS: I/R decreased the bradykinin-induced change in coronary flow (-5% +/- 4% versus 26% +/- 3% at equilibration; p < 0.05) and the SNP-induced change (+20% +/- 6% versus +56% +/- 5% at equilibration; p < 0.05). The coronary vasculature after H2O2 infusion revealed a similar loss in vasodilatory responsiveness (+4% +/- 4% in response to bradykinin, +35% +/- 8% in response to SNP; p < 0.05 versus equilibration). Pretreatment with CoQ improved BK-induced vasorelaxation after I/R (+12% +/- 2%; p < 0.05 versus control I/R) or H2O2 infusion (18% +/- 4%; p < 0.05 versus control I/R) but failed to improve SNP-induced vasorelaxation. The CoQ pretreatment decreased the I/R-induced maximal free radical burst (9.3 +/- 0.8 x 10(3) cpm versus 11.5 +/- 1.1 x 10(3) cpm; p < 0.05) during the early period of reperfusion.
CONCLUSIONS: Endothelium-dependent vasorelaxation is more sensitive than endothelium-independent relaxation to I/R injury. Via a direct antioxidant effect, CoQ preserved endothelium-dependent vasorelaxation by improving tolerance to I/R injury.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8751582     DOI: 10.1016/s0039-6060(96)80287-x

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  6 in total

1.  Coenzyme Q10 protects against acute consequences of experimental myocardial infarction in rats.

Authors:  Samy M Eleawa; Mahmoud Alkhateeb; Sanjoy Ghosh; Fahaid Al-Hashem; Abdullah S Shatoor; Abdulmohsen Alhejaily; Mohammad A Khalil
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2015-03-20

2.  Nutriceuticals in health and disease prevention.

Authors:  Simmi Kharb; Veena Singh
Journal:  Indian J Clin Biochem       Date:  2004-01

3.  Effect of coenzyme Q10 on risk of atherosclerosis in patients with recent myocardial infarction.

Authors:  Ram B Singh; Narankar Singh Neki; Kumar Kartikey; Daniel Pella; Adarsh Kumar; Mohammad Arif Niaz; Amar Singh Thakur
Journal:  Mol Cell Biochem       Date:  2003-04       Impact factor: 3.396

4.  Ex vivo resuscitation of adult pig hearts.

Authors:  Doreen Rosenstrauch; Hakan M Akay; Hakki Bolukoglu; Lars Behrens; Laura Bryant; Peter Herrera; Kazuhiro Eya; Egemen Tuzun; Fred J Clubb; Branislav Radovancevic; O H Frazier; Kamuran A Kadipasaoglu
Journal:  Tex Heart Inst J       Date:  2003

5.  Liposomal Antioxidants for Protection against Oxidant-Induced Damage.

Authors:  Zacharias E Suntres
Journal:  J Toxicol       Date:  2011-08-16

Review 6.  Supplementation of Coenzyme Q10 among Patients with Type 2 Diabetes Mellitus.

Authors:  Qiuhua Shen; Janet D Pierce
Journal:  Healthcare (Basel)       Date:  2015-05-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.